Exhibit 99.5

 

Joint Filing Agreement

 

In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, the persons and entities named below agree to the joint filing on behalf of each of them of the foregoing Schedule 13D with respect to the shares of common stock, par value $0.001 per share, of ReShape Lifesciences, Inc, and that all subsequent amendments to such Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned hereby further agree that this joint filing agreement be included as an exhibit to such Schedule 13D and that this joint filing agreement may be executed in any number of physical or electronically signed counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument. In evidence thereof, the undersigned, being duly authorized, have executed this joint filing agreement as of January 7, 2025.

   
  DOMINION CAPITAL LLC
 

By: Dominion Capital GP LLC, its Manager

By: Dominion Capital Holdings LLC, its Manager

 

  By: /s/ Mikhail Gurevich
    Name: Mikhail Gurevich
    Title: Authorized Signatory

 

 

  ASCENT PARTNERS FUND LLC

 

  By: /s/ Alon Brenner
    Name: Alon Brenner
    Title: Authorized Signatory

 

 

  DOMINION CAPITAL GP LLC
  By: Dominion Capital Holdings LLC, its Manager

 

  By: /s/ Mikhail Gurevich
    Name: Mikhail Gurevich
    Title: Authorized Signatory

 

 

  DOMINION CAPITAL HOLDINGS LLC

 

  By: /s/ Mikhail Gurevich
    Name: Mikhail Gurevich
    Title: Authorized Signatory

 

 

  /s/ Mikhail Gurevich
  Mikhail Gurevich

 

  /s/ Gennadiy Gurevich
  Gennadiy Gurevich

  

  /s/ Alon Brenner
  Alon Brenner

 

 

  

 

ReShape Lifesciences (NASDAQ:RSLS)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas ReShape Lifesciences.
ReShape Lifesciences (NASDAQ:RSLS)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas ReShape Lifesciences.